Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,148) with videos related to
Page
of 115
Sort By:
The Journal of General Physiology
|
November 9, 2023
Analogs of FTY720 inhibit TRPM7 but not S1PRs and exert multimodal anti-inflammatory effects
Gregory W Busey, Mohan C Manjegowda, Tao Huang, et al.
The Lancet. Neurology
|
June 20, 2025
Friedreich's ataxia-a rare multisystem disease
Kathrin Reetz, Stella A Lischewski, Imis Dogan, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2023
Novel TRPM7 inhibitors with potent anti-inflammatory effects <i>in vivo</i>
Gregory W Busey, Mohan C Manjegowda, Tao Huang, et al.
Journal of Lipid Research
|
July 19, 2022
Skin fibroblast metabolomic profiling reveals that lipid dysfunction predicts the severity of Friedreich's ataxia
Dezhen Wang, Elaine S Ho, M Grazia Cotticelli, et al.
Stroke
|
July 30, 2005
Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial
John R Lynch, Haichen Wang, Matthew J McGirt, et al.
Ecology and Evolution
|
January 9, 2023
"Where do I even start?" Recommendations for faculty diversifying syllabi in ecology, evolution, and the life sciences
Tolulope I N Perrin-Stowe, Melissa Horner, Jaime J Coon, et al.
Mitochondrion
|
December 15, 2010
Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function
Mary A Selak, Elise Lyver, Elizabeth Micklow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2004
Pain education for underserved minority cancer patients: a randomized controlled trial
Karen O Anderson, Tito R Mendoza, Richard Payne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 30, 2012
A0001 in Friedreich ataxia: biochemical characterization and effects in a clinical trial
David R Lynch, Steven M Willi, Robert B Wilson, et al.
The Journal of Biological Chemistry
|
April 23, 2002
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
Volker Brinkmann, Michael D Davis, Christopher E Heise, et al.
Page
of 115
Search research articles
Search
Showing results (991-1000 of 1,148) with videos related to
Sort By:
Page
of 115
The Journal of General Physiology
|
November 9, 2023
Analogs of FTY720 inhibit TRPM7 but not S1PRs and exert multimodal anti-inflammatory effects
Gregory W Busey, Mohan C Manjegowda, Tao Huang, et al.
The Lancet. Neurology
|
June 20, 2025
Friedreich's ataxia-a rare multisystem disease
Kathrin Reetz, Stella A Lischewski, Imis Dogan, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2023
Novel TRPM7 inhibitors with potent anti-inflammatory effects <i>in vivo</i>
Gregory W Busey, Mohan C Manjegowda, Tao Huang, et al.
Journal of Lipid Research
|
July 19, 2022
Skin fibroblast metabolomic profiling reveals that lipid dysfunction predicts the severity of Friedreich's ataxia
Dezhen Wang, Elaine S Ho, M Grazia Cotticelli, et al.
Stroke
|
July 30, 2005
Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial
John R Lynch, Haichen Wang, Matthew J McGirt, et al.
Ecology and Evolution
|
January 9, 2023
"Where do I even start?" Recommendations for faculty diversifying syllabi in ecology, evolution, and the life sciences
Tolulope I N Perrin-Stowe, Melissa Horner, Jaime J Coon, et al.
Mitochondrion
|
December 15, 2010
Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function
Mary A Selak, Elise Lyver, Elizabeth Micklow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2004
Pain education for underserved minority cancer patients: a randomized controlled trial
Karen O Anderson, Tito R Mendoza, Richard Payne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 30, 2012
A0001 in Friedreich ataxia: biochemical characterization and effects in a clinical trial
David R Lynch, Steven M Willi, Robert B Wilson, et al.
The Journal of Biological Chemistry
|
April 23, 2002
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
Volker Brinkmann, Michael D Davis, Christopher E Heise, et al.
Page
of 115